Zimmer Biomet Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Zimmer Biomet Holdings, Inc. (ZBH) on January 12, 2026, covering events occurring on January 8, 2026. The company is incorporated in Delaware and its common stock and various notes are traded on the New York Stock Exchange.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses on corporate governance changes rather than financial performance data.
Material Changes
- Executive Departure: Mark Bezjak, a named executive officer in the 2025 proxy statement, notified the company of his resignation from all employment and officer positions, effective January 16, 2026.
- Reason for Departure: Mr. Bezjak is resigning to pursue another business opportunity.
- Prior Status: The filing notes that Mr. Bezjak had previously ceased to be an executive officer of the company on July 1, 2025.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The report is limited to the disclosure of the officer's departure and the inclusion of a cover page interactive data file.
Investor Verification Checklist
- Confirm the effective date of Mark Bezjak's resignation (January 16, 2026).
- Verify the succession plan or interim leadership arrangements for the roles vacated by Mr. Bezjak.
- Review the 2025 proxy statement to understand Mr. Bezjak's prior roles and compensation history.
- Check for any subsequent filings regarding the appointment of a replacement officer.